Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma M Groarke

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|January 7, 2021
Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemiaEmma M Groarke, Bhavisha A Patel, Fernanda Gutierrez-Rodrigues, et al.
Haematologica|September 30, 2021
Utility of plasma cell-free DNA for <i>de novo</i> detection and quantification of clonal hematopoiesisFernanda Gutierrez-Rodrigues, Isabel Beerman, Emma M Groarke, et al.
British Journal of Haematology|July 18, 2024
Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemiaAshvind Prabahran, Jibran Durrani, Juan Coelho-Da Silva, et al.
Annals of the Rheumatic Diseases|June 28, 2025
Disease Trajectories and Glucocorticoid Exposure in VEXAS Syndrome Treated with Cytokine-Directed TherapiesBenjamin A Turturice, Alice Fike, Bhavisha A Patel, et al.
Leukemia|April 22, 2026
Imputing causality and clonal dynamics from single-cell transcriptomics in paroxysmal nocturnal hemoglobinuriaHiroki Mizumaki, Shouguo Gao, Zhijie Wu, et al.
JAMA Dermatology|June 12, 2024
Skin Manifestations of VEXAS Syndrome and Associated GenotypesIsabella J Tan, Marcela A Ferrada, Serene Ahmad, et al.
Nature Communications|May 20, 2025
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndromeHiroki Mizumaki, Shouguo Gao, Zhijie Wu, et al.
Haematologica|January 8, 2026
Telomere attrition is common in patients with germline <i>RUNX1</i> pathogenic variantsRialnat A Lawal, Fernanda Gutierrez-Rodrigues, David J Young, et al.
Blood|November 1, 2021
HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemiaYoshitaka Zaimoku, Bhavisha A Patel, Sharon D Adams, et al.
Blood Advances|March 14, 2025
Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapyJibran Durrani, Leonard N Chen, Ruba N Shalhoub, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|January 7, 2021
Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemiaEmma M Groarke, Bhavisha A Patel, Fernanda Gutierrez-Rodrigues, et al.
Haematologica|September 30, 2021
Utility of plasma cell-free DNA for <i>de novo</i> detection and quantification of clonal hematopoiesisFernanda Gutierrez-Rodrigues, Isabel Beerman, Emma M Groarke, et al.
British Journal of Haematology|July 18, 2024
Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemiaAshvind Prabahran, Jibran Durrani, Juan Coelho-Da Silva, et al.
Annals of the Rheumatic Diseases|June 28, 2025
Disease Trajectories and Glucocorticoid Exposure in VEXAS Syndrome Treated with Cytokine-Directed TherapiesBenjamin A Turturice, Alice Fike, Bhavisha A Patel, et al.
Leukemia|April 22, 2026
Imputing causality and clonal dynamics from single-cell transcriptomics in paroxysmal nocturnal hemoglobinuriaHiroki Mizumaki, Shouguo Gao, Zhijie Wu, et al.
JAMA Dermatology|June 12, 2024
Skin Manifestations of VEXAS Syndrome and Associated GenotypesIsabella J Tan, Marcela A Ferrada, Serene Ahmad, et al.
Nature Communications|May 20, 2025
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndromeHiroki Mizumaki, Shouguo Gao, Zhijie Wu, et al.
Haematologica|January 8, 2026
Telomere attrition is common in patients with germline <i>RUNX1</i> pathogenic variantsRialnat A Lawal, Fernanda Gutierrez-Rodrigues, David J Young, et al.
Blood|November 1, 2021
HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemiaYoshitaka Zaimoku, Bhavisha A Patel, Sharon D Adams, et al.
Blood Advances|March 14, 2025
Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapyJibran Durrani, Leonard N Chen, Ruba N Shalhoub, et al.
Pageof 5